Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+85.5%
5Y CAGR+42.3%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+85.5%/yr
Quarterly compound
5Y CAGR
+42.3%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 75.52% |
| Q4 2025 | 4.89% |
| Q2 2025 | -27.49% |
| Q1 2025 | 38.24% |
| Q4 2024 | -2.08% |
| Q3 2024 | 0.24% |
| Q2 2024 | -0.05% |
| Q1 2024 | -0.66% |
| Q4 2023 | -26.40% |
| Q3 2023 | 32.52% |
| Q2 2023 | 9.47% |
| Q1 2023 | -0.57% |
| Q4 2022 | 11.83% |
| Q3 2022 | 0.09% |
| Q2 2022 | 0.09% |
| Q1 2022 | -2.30% |
| Q4 2021 | -2.41% |
| Q3 2021 | 0.12% |
| Q2 2021 | 40.75% |
| Q1 2021 | 0.09% |
| Q4 2020 | 12.94% |
| Q3 2020 | 1.34% |
| Q2 2020 | 1.33% |
| Q1 2020 | 1.52% |
| Q4 2019 | 17.27% |
| Q3 2019 | -0.42% |
| Q2 2019 | 1.43% |
| Q1 2019 | 1.55% |
| Q4 2018 | 1.31% |
| Q3 2018 | 3.63% |
| Q2 2018 | 1.63% |
| Q1 2018 | 1.17% |
| Q4 2017 | 1.70% |
| Q3 2017 | -0.76% |
| Q2 2017 | 1.41% |
| Q1 2017 | 1.19% |
| Q4 2016 | 19.50% |
| Q3 2016 | -0.45% |
| Q2 2016 | 1.27% |
| Q1 2016 | 1.26% |